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Abstract: Desirable carbon allotropes such as graphene oxide (GO) have entered the field with
several biomedical applications, owing to their exceptional physicochemical and biological features,
including extreme strength, found to be 200 times stronger than steel; remarkable light weight; large
surface-to-volume ratio; chemical stability; unparalleled thermal and electrical conductivity; and
enhanced cell adhesion, proliferation, and differentiation properties. The presence of functional
groups on graphene oxide (GO) enhances further interactions with other molecules. Therefore,
recent studies have focused on GO-based materials (GOBMs) rather than graphene. The aim of this
research was to highlight the physicochemical and biological properties of GOBMs, especially their
significance to biomedical applications. The latest studies of GOBMs in biomedical applications are
critically reviewed, and in vitro and preclinical studies are assessed. Furthermore, the challenges
likely to be faced and prospective future potential are addressed. GOBMs, a high potential emerging
material, will dominate the materials of choice in the repair and development of human organs and
medical devices. There is already great interest among academics as well as in pharmaceutical and
biomedical industries.
Keywords: graphene; graphene oxide; functionalization; interface; stem cells; cell adhesion; carbon;
human organs; 3D scaffold
1. Introduction
Trauma, aging, and disease cause damage to tissue, which can result in loss of func-
tion. In the early stages, self-healing can be effective, but with substantial injury, the organ
cannot restore itself sufficiently; thus, organ repair or replacement (autograft or allograft)
is recommended, albeit with some challenges. The most critical challenges facing organ
replacements are organ shortages, grafts, transplant rejection, high cost, inflammation,
infection, and also death in some cases [1]. Alternatively, tissue engineering has attracted
considerable attention due to its significant potential for tissue restoration. Tissue engineer-
ing is a combination of active molecules, cells, and also a scaffold that accurately mimics
the extracellular matrix [2]. An optimal scaffold should be nontoxic, porous, provide me-
chanical strength and proper cell attachment, and, consequently, induce cell proliferation
and differentiation [3].
Carbon-based nanomaterials have recently boomed in biomaterial applications.
Graphene is an important new addition to these carbon family materials due to its
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unique properties. Researchers in tissue engineering have already extensively investigated
graphene-containing structures, specifically for bone, neuronal, cardiac, skin, cartilage,
and dental tissue regeneration, as highlighted in graphical abstract. Carbon-based nano-
materials have recently boomed in biomaterial applications. Graphene is an important
new addition to these carbon family materials due to its unique properties. Researchers in
tissue engineering have already extensively investigated graphene-containing structures,
specifically for bone, neuronal, cardiac, skin, cartilage, and dental tissue regeneration, as
highlighted in Figure 1.
 
–
Figure 1. Schematic of graphene oxide nanomaterials and their application in tissue engineering,
particularly in nerve, muscle, heart, skin, cartilage, dental, and other tissues.
In this review, graphene oxide (GO), reduced graphene oxide (rGO), and function-
alized GO (FGO) are noted among the various allotropic forms of carbons due to their
significant surface area, strength, light weight, chemical stability, enhanced cell adhesion,
proliferation, differentiation, and application in the repair of tissue [4,5]. The basic structure
of all carbon allotropes is graphene; it is a single sheet of sp2-hybridized carbon atoms ar-
ranged in a hexagonal lattice-like honeycomb. Valuable research has completely described
the synthesis method, but in brief, the synthesis approach was divided into top-down
and bottom-up strategies. In the top-down approach, graphite is treated by exfoliation
(mechanical or electrochemical). The bottom-up approach is a developed approach, which
contains epitaxial growth, chemical vapor deposition, and the dry ice method for graphene
material production [6–8] (Figure 2).
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Figure 2. Graphene, graphene oxide, and reduced graphene oxide synthesis methods [9].
Two-dimensional (2D) graphene lattice structures have some shortcomings, such as an
unstable chemical structure and limited active sites for interacting with other molecules or
nanomaterials; hence, it has some incompatibility. The chemical modification of graphene
and the production of GO resolves some of these problems. GO maintains graphene’s
atomic configuration and only has carboxyl groups (-OOH) on the edge of its structure,
as well as epoxy (-O) and hydroxyl (-OH) groups on the basal plane. By reducing the
amount of oxygen in GO through thermal, chemical, or UV exposure processes, rGO is
produced. Most often, the reduction of GO does not complete, and some oxygen groups
remain because not all sp3 bonds could return to the sp2 structure [10]. rGO promotes the
cell differentiation and mechanical properties of scaffolds, although there is no apparent
effect on scaffold hydrophilicity [11]. Thus, the repair and replacement of organs using
tissue engineering strategies have focused on GO, FGO, and rGO more than graphene.
The aim of this research was to highlight the physicochemical and biological properties of
GO-based materials (GOBMs) and critically review the literature over the last three years
on the applications of these materials in the repair and development of human organs.
2. Graphene and Its Physicochemical Properties
The distinctive properties of graphene are derived from its particular crystal lattice
structure. Within this, the bonding between each carbon atom is hybridized sp2 with the
addition of π orbitals. In each unit cell of graphene, two π orbitals exist that are dispersed
to form two π bonds, both of which could be known as bonding and antibonding [12].
This arranged lattice is a fundamental building block for all graphitic materials in various
dimensions, namely (1) zero-dimensional (0D), e.g., carbon dot, fullerenes and nanodia-
mo ds; (2) rolled one-dimensional (1D), e.g., carbon nanotubes; (3) two-dimensional (2D),
e.g., graphene and GO; and (4) stacked three-dimensional (3D), e.g., graphite [13]. The
graphene family structure also results in an exceptional surface-to-volume ratio, high in-
trinsic mobility, unparalleled thermal conductivity, and excellent electrical, optoelectronic,
and mechanical properties that have paved the way due to being attractive technological
tools [12,14]. Graphene is renowned as one of the most robust materials known to humans,
and it is found to be 200 times stronger than steel [15]. In GO, hydrogen bonding forms be-
tween hydroxyl and epoxy groups and weak interactions with other groups. The existence
of the carboxylic acid group offers a negative surface charge (hydrophilic section); therefore,
GO has stability in different polar solutions (particularly water), while graphene is inclined
to aggregation. Moreover, owing to free surface π electrons from unmodified graphene
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(hydrophobic section), GO has an amphiphilic structure that could act as a surfactant.
Graphene is hydrophobic, and GO, in comparison with graphene, could be hydrophilic or
hydrophobic depending on the chemical and functionalization of the surface chemistry.
These characteristics make GO the most important derivative of graphene, which possesses
an easy process and a high affinity to accommodate biomolecules. The enhancement of
chemical reactivity and graphene stability in solution is intertwined with the presence of
reactive oxygen functional groups. Disrupted sp2 reduces its mechanical, electrical, and
thermal properties [12,14]. Although rGO has less oxygen content, hydrophilic functional
groups, or surface charge, through the modification of noncovalent interactions (e.g., van
der Waals interactions and π–π stacking), the physical adsorption of both polymers and
small biomolecules onto its basal plane is enhanced remarkably [16].
3. Graphene Oxide and Its Biological Properties
It has been proven that most GO and derivatives are cytocompatible in vitro and
in vivo. However, the physicochemical properties of 2D materials, such as structure, shape,
size, surface functionality, concentration, and aggregation state have an essential impact
on cellular behavior. Graphene, with its sharp edge properties, has the potential to cause
cell damage during the penetration of cell membranes. Its aggregation can also lead to
cytotoxicity. Graphene at the nanoscale, when <100 nm, results in cytotoxicity, inflamma-
tion, and even genotoxicity (due to facing less steric hindrance). In contrast, graphene
with functionalized groups (i.e., GO, FGO such as the amine group, and rGO) is easily
internalized by cells (especially in nano sizes), in addition to causing more irregular cell
membrane perturbation [12,17]. GO and its derivatives have been ascertained to have
specific antibacterial properties, which are also emphasized in tissue engineering appli-
cations [18]. The antibacterial activity of GO is related to various mechanisms, including
membrane stress, oxidative stress, entrapment, the basal plane, and the photothermal effect.
GO has sharp edges that damage the cell membrane, meaning it could, in turn, lead to
bacterial cell mortality via the membrane stress mechanism. The structure of GO allows it
to act as an electron acceptor; thus, in the vicinity of bacteria, the abstraction of electrons
within the membrane occurs, compromising membrane integrity and killing bacterial
cells (particularly P. aeruginosa and S. aureus). GO and rGO, owing to the existence of
functionalized groups, can alter the partial pressure of intracellular oxygen, which results
in oxidative damage that destroys the bacterial cell internal composition, particularly E.
coli, through the deactivation of their proteins and lipids, which eventually leads to cell
death. GO has illustrated synergistic effects with laser energy; hence, it has been used for
photothermal therapy, directly enhancing its antibacterial activity [19]. Another fascinating
property that GOBMs possess is antioxidant activity, and sp2 carbons play an essential
role in scavenging radicals by radical adduct formation and electron transfer. Because of
this characteristic, these biomaterials can effectively scavenge radicals and protect cells
from high levels of oxidative stress [20]. Graphene, being nonbiodegradable (except FGO),
presents serious concerns for potential toxicity, immune response, and environmental
hazards [21]. It is reported that GO is susceptible to biodegradation by oxidative attack
through hydrogen peroxide and horseradish peroxidase. Therefore, many attempts, such as
the fabrication of nanocomposites, have been carried out to accelerate GO biodegradation,
as the degradation rate of biomaterials (i.e., scaffold) must be compatible with the rate of
tissues and organs [15,22,23].
4. Development of Tissues and Organs Using Graphene-Based Materials
GO and its derivatives have been added to other biomaterials either as filler to enhance
their properties or as a conjugate during synthesis. The latter makes the nanocomposite
materials much stronger. Below are examples of the applications of graphene derivatives
in the repair and replacement of human organs (Table 1).
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Table 1. Summary of preclinical studies of graphene-oxide-based materials in tissue engineering from 2017.
Organs Materials Animal Cells/Stem Cells Experiment Outcome
Year [Ref]
Country





Preparing nano-GO (NGO) solution =>
hydrogel crosslinking => three groups:
non-crosslinked hydrogel (NGO (U)),
crosslinked hydrogel (NGO(T)), control
group (G)
NGO(T) vs. NGO(U): ↑ mechanical
properties. No significant cytotoxicity
After implantation (8 weeks): fibrous tissue











Coating GO on ApF/PLCL nanofibers =>
GO reduction => applying ES => preparing
the AP/RGO nerve guidance conduit
↑ CPAM and ↑ MPs. GO: ↑ focal adhesion
kinase expression of PC12 cells. ↑ Repair in







Incorporating GO into PAAm (GO-PAAm)
=> micropatterning of GO-PAAm with
femtosecond laser ablation (FLA) =>
production of micropatterned conductive
r(GO/PAAm)
Micropatterned:
↑ differentiation and myoblast alignment
r(GO/PAAm) vs. GO/PAAm: ↓ impedance
values PD50/r(GO/PAAm) (optimum):
↑ tissue compatibility and
ES => ↑ myogenesis.
2019 [26]
Korea




GO/Ag blend => hMSCs encapsulation =>
electrospraying and then crosslinking =>
GO/Ag microgels => reductive treatment
=> r(GO/Ag)
rGO vs. GO: ↑ CPAM,
↑ antioxidant activity, and ↓ Oxidative stress
hMSCs-CMs vs. CMs: ↑ cell viability and










Synthesizing GO => PCL/GO pellets =>
melt blending => 3D printing
↑ Protein absorbent and ↑ CPAM
↓ Immunogenicity. Treating a rat calvaria
critical size defect => well-organized tissue











RAW 2467 cells and
C2C12 myoblast cells
Dispersing pGO into CS/SF mixture=>
dual-crosslinking by poly(ethylene glycol)
diglycidyl ether (PEGDE) and
glutaraldehyde (GA) => freeze-drying =>
pGO-CS/SF scaffold
↑ CPAM and ↑ mechanical properties
↑ Antioxidant activity => reduce cellular
oxidation. Well-connected electric pathway
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Table 1. Cont.










Fabricating nanoscaffolds => seeding
Schwann cells => implanting the 3D
scaffold in sciatic nerve defect models.
↑ CPAM and ↑ neural cell
expressionPDA/RGD-SG/PCL and













GO => embedding with AuNPs by
thermal-reduction => GO-AuNPs => CS
solution addition and freeze-drying =>
CS-GO-Au scaffolds
↑ Electrical conductivity (at 0.5% w/v GO-
AuNPs).
↑ CPAM, no immune response
↑ QRS interval (by ↑ conduction velocity and
↑ contractility). ↑ Connexin43 (Cx43)












Coating GO/CS/HA on Ti substrates by
electrophoretic deposition (EPD)
↑ CPAM and ↑ osseointegration in vivo
2018 [32]
China
Dental GO and Collagen Dog
Mouse osteoblastic
MC3T3-E1 cells
Coating Ti on the 3D collagen scaffold =>
evaluation of bone augmentation on the rat
cranial bone => assessing the periodontal
healing of class II furcation defects
↓ Cytotoxicity.
GO: cellular ingrowth behavior and






GO, rGO, and Gelatin Rats
Embryonic neural
progenitor cells
Synthesizing rGO microfibers from GO =>
assembling rGO microfibers into the 3D
gelatin hydrogel for stable implantation
Microfiber coated with adhesive molecules
=> interconnected culture
↑ Differentiation in the defect site
2017 [34]
Spain





CHT/GO blend => freeze-drying
↑ Alkaline phosphatase activity (ALP), ↑
osteogenesis, and ↑ bone morphogenetic
protein expression
↑ Differentiation of osteoprogenitor cells










Self-assembling of GO and nHA =>
nHA@RGO
↑ CPAM, ↑ ALP, and ↑ osteogenic
gene expression
↑ Healing circular calvarial defects (optimum:
20% nHA@RGO)
↑ Collagen deposition and ↑ mineralization
2017 [11]
China
Keys: ↑, increased or improved; ↓, decreased; =>, followed by; CPAM, cellular proliferation, adhesion, and migration; SD, Sprague–Dawley; MPs, mechanical properties; HM, Hummer’s method; ES,
electrical stimulation.
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Having drastic proliferation and differentiation of stem cells into the specific tissue
lineage, considered as the most critical features of an ideal scaffold. As mentioned before,
GBMs have considerable potential for cells stimulating in stem cell-based therapy. In
Table 2, we summarized the most common stem cells utilized for each tissue.
4.1. Nerve Muscle and Cardiac Tissue Engineering
Electrical signals and external stimuli enhance tissue regeneration for excitable tissue,
specifically nerve, muscle, and cardiac tissue. Depolarization and repolarization take place
between the two sides of both nerve and muscle cell membranes under an action potential,
which leads to their contracting activity and response to electrical signals. Conductive
materials, such as GOBMs, with similar electrical conductivity to native tissue, are con-
sidered to be promising scaffolds that stimulate cell proliferation and differentiation in
stem-cell-based therapy, with decreased cytotoxicity and improved mechanical properties.
They are better electron transmitters in comparison to other electronic materials, such as
carbon nanotubes [30]. Much effort has been made to repair neuronal injuries, assisted by
GOBMs to provide the signaling pathways between cells [36]. Despite the acceptable cellu-
lar outcome of GO film in neural tissue regeneration, the precoating of GO by polymers
(e.g., collagen, laminin, poly-L-lysine (PLL), or PDL) could improve cell adhesion. There is
also no preference between utilizing graphene or GO film because neural differentiation
is affected by different fabrication approaches and different cell types [37]. Furthermore,
Zhang et al. demonstrated the enhanced neural differentiation of a GO mat compared to
an rGO mat by immersing the modified glass in 1.5 mg/mL of GO aqueous solution and
then reduced the oxygen-containing groups to obtain an rGO mat [38]. The outstanding
properties of the 3D structures of GO, such as electrospun mats, foam, hydrogels, and
layer-by-layer casting (LBLC), in addition to their supportive role in cell viability and
neural cell differentiation, are its sufficient porosity, which facilitates nutrient exchange
and a high surface/volume ratio, which provides highly conductive pathways for charge
transport in neural networks [37,38]. Biodegradable materials, including polycaprolactone
(PCL) and poly(lactic-co-glycolic acid) (PLGA), are the most popular polymers along with
GOBMs proposed in electrospinning nerve tissue engineering in recent years [25]. In
the electrospinning design, achieving an optimal GO concentration is substantial, as GO
concentration affects the physicochemical structure, mechanical properties, and eventually
the biological properties of the material. Thus, manufacturing a scaffold with a varied GO
concentration is necessary. GO concentration can affect the fiber diameter in electrospun
mats. Subsequently, GO concentration can affect cellular colonization in the scaffold, which
is another important parameter in nerve tissue engineering [39]. Apart from the important
effect of GO concentration, the dryness or wetness state of the scaffold also affects its final
properties. A new study in 2021 revealed that the conductivity, metabolic activity, and
cell proliferation of the scaffold, which is a combination of silk fibroin and GO (or rGO),
increases after hydration [40]. Due to the limited dispersibility of graphene-based materials
(particularly pure graphene) in solvents, the conventional electrospinning method is not
considered to be an efficient strategy. Thus, in novel approaches, GOBMs are coated on the
surface of the nanofibrous scaffold instead of encapsulated in fibers, with no damaging
effect on the nanofibrous structure [25,37,41]. Juan and coworkers demonstrated that
Schwann cells can upregulate various myelin gene expressions and also release many neu-
trophils to support nerve regeneration in rGO-coated electrospun mats. The nanofibrous
mat was saturated at the amount of 1.4% rGO, and the electrical conductivity was revealed
to be 4.05 × 10−2 S/m [25]. The LBLC method was utilized to fabricate the 3D porous
graphene conduit, considered an altered electrospinning method. In this method, adhesive
macromolecules coated single and multilayered GO/PCL nerve conduits (Figure 3A). Via
an integrated 3D-printing and LBLC procedure, the nanoscaffolds revealed a perfect cellu-
lar behavior. Due to the potency of GOBMs in nerve regeneration, there are some endeavors
to develop a new class of these biomaterials, particularly in inorganic conditions. A unique
hybrid scaffold made of a transition metal, synthetic Mo0.25Co1.257W0.25S3 hybridized with
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GO (MCWS/GO), was prepared, which led to successful nerve regeneration and recovery
within 2–5 weeks after MCWS/GO transplantation [42].
concentration of 10 μg
Figure 3. Schematic illustration of (A) the LBLC graphene nerve conduit. (a) The green layers are PDA/RGD adhesive
macromolecules. The purple layer is single or multilayered graphene and the PCL-blended layer. The blue layer is the
graphene and PCL-blended layer once more. (b) The GO/PCL nerve conduit in a sciatic nerve defect model in SD rats.
Reused with permission from [30]. Copyright © 2021, Springer Nature. (B) rGO/alginate microgel embedding MSCs
for cardiac tissue repair post-MI. Due to the loaded rGO, it was expected that encapsulated MSCs were protected from
the severe oxidative stress in the infarcted tissue and facilitated cardiac regeneration. Reused with permission from [27].
Copyright © 2021, Elsevier Ltd. (C) CS-DA-GO composite hydrogel fabrication in three steps, which causes the enhanced
properties of the hydrogel. (A) Self-healing mechanism of the hydrogel. (B) Self-adhesiveness of the hydrogel. (C) Enhanced
conductivity. Reused with permission from [29]. Copyright © 2021, Elsevier Ltd.
Similar to the nerves, muscles (skeletal, cardiac, and smooth) have an electrical stimuli-
responsive characteristic; thus, the utilization of conductive biomaterials was proposed.
There was no difference in cell adhesion and cellular growth in a random and aligned GO
electrospun mat, which was modified with oxygen plasma [43]. GO-polyurethane (PU)
foam is considered to be a beneficial scaffold for myogenesis in skeletal tissue engineering.
This scaffold is fabricated by the dip-coating method with a biocompatible concentration
of 10 µg/mL for GO. The results showed enhanced spontaneous myogenic differentiation
without any myogenic factors [44]. Xin et al. designed a muscle-inspired, self-healing,
conductive, and also self-adhesive hydrogel through the combination of chitosan (CS), GO
(lower than 0.75 mg/mL), and polydopamine (PDA). PDA has a great binding ability to a
variety of materials. Chemically crosslinked networks enhanced electrical conductivity and
also increased adhesive features caused by the presence of DA in the hydrogel (Figure 3C).
The electrical conductivity of the hydrogel was revealed as 1.22 ms/cm, matching the
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native myocardium. The cell results also showed increased stem-cell-derived fibroblast
and cardiomyocyte (CM) adhesion [29].
As mentioned, cardiac muscles are electrically conductive (0.03 to 0.6 S/m3); hence,
conductive biomaterials (especially with polymeric substrates) are potential candidates
that can mimic the native extracellular matrix (ECM) for cell growth, promote electrical
signal conduction, and preserve electrical coupling between the myocardium cells [45–47].
The incorporation of GOBMs could treat various cardiac disorders, including cardiac
regeneration after myocardial infarction (MI) [31,48], conduction disorders, and restora-
tion [31,46,48] Particularly in the case of MI, GOBMs can overcome the high oxidative stress
in the infarcted tissue due to antioxidant activity (Figure 3B) [27]. A combination of other
biomaterials, mostly GO and rGO, could be used for developing blood vessels [49] and
heart valves [50] to overcome the malfunctions and seems to be an attractive alternative to
mechanical and biological prostheses due to high durability, high biocompatibility, and
being hemodynamic. Through electrospinning, random and aligned nanofibrous matrices
can be fabricated to enable the investigation of isotropic conductivity [48,51]. To this aim,
blends of silk fibroin with GO (SF/GO) and rGO (SF/rGO) were prepared for random
and aligned electrospinning in a previous study, which resulted in superior electrical
conduction properties in SF/rGO (from a mean resistance of 4866.7 MΩ to 4.3 MΩ) in
a concentration-dependent manner. The aligned nanofibers not only caused anisotropic
conductivity but also aligned and strengthened sarcomeric structures, with an optimum
rGO thickness of ~100 nm. The concentration of 0.02–0.08 mg/mL rGO fundamentally
enhanced the expression of cardiac-specific proteins, the formation of gap junctions, beat-
ing rate, cardiac tissue contraction, and regeneration [48]. Micro- and nanopatterning is
another method to develop anisotropic conductive scaffolds to enhance the biomimicry
of cardiac tissue constructs. Smith et al. transferred GO films onto polymeric, polyethy-
lene glycol (PEG), and topographic substrates [52]. The electroconductive scaffold had a
7.071 ± 0.124 KΩ resistance in the transverse orientation, which indicated an increment
in the myofibril and sarcomere property, cell–cell coupling and calcium-handling protein
expression, and action potential [52]. In several studies, other conductive scaffolds (i.e.,
hydrogels, microgels, sponges, and foams), with a combination of GOBMs, fabricated and
fundamentally improved cardiac regeneration and function [27,31,46,53].
4.2. Bone Tissue Engineering
The bone has a prominent ability to regenerate; however, the human skeleton has a
limited capacity of self-regeneration when bone defects are large enough or critical sized.
Several different approaches have been utilized for bone tissue engineering (BTE); the most
common were those that tried to mimic the natural process of bone repair using 3D osteo-
conductive scaffolds. Recently, the potential of GOBMs has gained tremendous attention to
facilitate and improve BTE [54–59] in its various forms, namely scaffolds, coatings, guided
bone membranes, and drug delivery systems [60]. Moreover, GOBMs, particularly with
low oxygen contents, have a pivotal influence on adult mesenchymal stem cells (MSCs)
to increase osteoinductivity and osteoconductivity [11,61]. Bone is a piezoelectric tissue;
hence, using GOBMs, they supply either essential mechanical and biological requirements
or electrical conductivity [28]. GOBMs, rGO in particular, could enhance levels of bio-
compatibility, alkaline phosphatase activity, and calcium deposits, which are essential for
bone regeneration [62]. Biphasic calcium phosphate (BCP) coated with rGO (BCP-rGO)
at various concentrations was fabricated in a previous study. Briefly, the prepared bone
graft materials were implanted in rats with calvarial defects, the common model for in-
vestigating new bone regeneration (Figure 4B). The grafting resulted in a new volume of
bone formation after eight weeks, particularly in a specimen with a concentration ratio of
4:1000 rGO:BCP (7.65 ± 1.39 mm3). The results indicated rGO enhances bone regeneration,
although when the rGO percentage exceeded a certain threshold level (≥100 µg/mL), it
became severely cytotoxic, [63] which complies with other studies [11,28,60,64]. Recently,
researchers have developed 3D-printed scaffolds entailing GOBMs to mimic not only bone
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geometry but also bone remodeling. Wang et al. fabricated a novel 3D-printed scaffold
made of poly(ε-caprolactone)/graphene. As expected, the addition of small concentrations
of GO enhanced mechanical properties and osteogenesis (by applying electrical stimulation,
10 µA), which led to a better bone defect treatment and bone deposition [28]. Additionally,
GOBMs (GO and rGO in particular) presented antimicrobial activity without compromising
osteoblasts’ viability, attachment, and proliferation (Figure 4A) [58,65]. A key characteristic
of GOBMs is the ability to induce bone differentiation, which leads to rapid bone repair. It
has been reported that bioinspired composite scaffolds based on gelatin and GO (GG) could
induce the bidirectional differentiation of bone marrow stromal cells (BMSCs) by activating
the Erk1/2 and AKT pathway. The presence of GG created the initial hypoxia, which
gradually transformed into a well-vasculature robust condition with the bidifferentiation
of BMSCs in calvarial defect models [66].
ɛ




Figure 4. (A) Pseudocolored SEM images of human osteoblasts that successfully adhered to the surface of scaffolds at an
upward trend (Days 1, 3, and 7). Reused with permission from [58]. Copyright © 2021, Elsevier Ltd. (B) Surgical procedure
of the preparation of the surgical size defect (5 mm) critical in the rat calvarium (a–c), placement of the chitosan–graphene
oxide scaffold (d), and closure of the periosteum and skin (e,f). Reused with permission from [64]. Copyright © 2021,
Springer Nature.
4.3. Skin Tissue Engineering
The skin acts as a vital barrier, blocking the entrance of dangerous foreign matter into
the body [67]. Because of this significance, GOBMs have been applied for skin regeneration
by wound dressings [68] or skin monitoring via electronic skin [69]. Wound dressings, in
the form of electrospun mats [70,71], hydrogels [68,72], and sponges, [73] are the best option
to accelerate wound healing; hence, GOBMs have been incorporated within these forms of
dressings, although other shapes (e.g., modified rGO nanosheets [74]) could also provide
drastic novel treatment options. Tang and coworkers fabricated an inspired scaffold by
mussel chemistry, based on polydopamine-rGO (pGO) that was incorporated in chitosan
(CS) and silk fibroin (SF) hydrogel (pGO-CS/SF). Due to the pGO, electroactivity responded
to electrical signals and increased cytological behavior (Figure 5A) [68]. Antioxidant activity
reduced cellular oxidation by removing excessive radical oxygen species (ROS) [68,75]. It
is a plus that rGO could substantially enhance angiogenesis, which is massively beneficial
for slow-healing/chronic wounds [76]. Alongside these applications, it is necessary to
recognize the GOBMs and their interactions with the skin, as it is one of the main exposing
routes of materials [67,77]. The effects of GO and few-layer graphene (FLG) with HaCaT
keratinocytes were investigated. FLG (>5 µg/mL) and mainly GO (~2–5 µg/mL) in long
exposure times increased the level of ROS and led to mitochondrial and plasma membrane
damages [67,77]. Our own experience with skin regeneration is the development of a
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membrane from an FGO-based nanocomposite with a hydrophobic outer layer with low
porosities to keep bacteria away from the skin, while the inner layer was hydrophilic and
more porous to seed with stem cells and growth factors.
Figure 5. (A) Wound healing of the skin through the treatment of various scaffolds. (a) Model of wound regeneration.
Digital images (b) and closure rate (c) of the wound defects; multiple treatments at Days 0, 7, 14, and 21. (d) Depictive
images of H&E-stained histological sections after 21 days (arrows indicate the granulation tissue). Reused with permission
from [68]. Copyright © 2021 American Chemical Society. (B) (a) A normal rat knee joint; (b) knee joint restoration in
different experimental groups (M: without implant; GO-NGO (U): non-crosslinked hydrogel; GO-NGO (T): microplasma
crosslinked hydrogel) i 4 and 8 weeks. Reused with permission from [24]. Copyright © 2021 American Chemical Society.
4.4. Cartilage Tissue Engineering
Cartilage is an avascular tissue that has limited self-healing potential compared to
other tissues [78]. Thus, utilizing a proper microenvironment for chondrogenic differentia-
tion will eventually lead to a hyaline-cartilage-like formation. GOBMs in cartilage tissue
engineering (CTE) are recognized as promising substitutes due to their self-lubricating and
antiwear properties, as well as enhanced mechanical properties, in addition to improved
biological behavior [79]. Chitosan/poly(vinyl alcohol) (PVA)/GO (6 wt %) electrospun
mats with a 1.81 MPa tensile strength are considered promising when used to reinforce
scaffolds in CTE [80]. Yeqiao et al. fabricated a PVA/GO-PEG nanocomposite hydrogel
using the freezing/thawing method. The presence of PEG caused the efficient grafting of
PVA molecules on the GO surface. The tensile strength, elongation at break, and compres-
sive modulus increased. Furthermore, for samples with a 1.5% GO content, the maximum
force retention and dynamic stiffness were improved. In composite hydrogel, the friction
coefficient decreased by more than 50% [79]. The small amount of nanographene oxide
(NGO) (1 wt %) enhances both the mechanical and biomedical features of microplasma
crosslinked gelatin-based hydrogel and provides hyaline cartilage formation without ex-
pensive growth factors (Figure 5B). Gelatin methacrylate (GelMa)-poly(ethylene glycol)
diacrylate (PEGDA)-GO is a novel cartilage printing ink that increased glycosaminogly-
can and collagen levels after the GO-induced chondrogenic differentiation of hMSCs [81].
Seifalian and coworkers have been working on the development of the ear for auricular
cartilage reconstruction for children with microtia [82]. Recently, they used an FGO-based
nanocomposite as a 3D microporous scaffold with adipose-derived stem cells [83].
4.5. Dental Application
Most studies in dental tissue engineering have emphasized the role of GOBMs in
the osteogenic differentiation of stem cells after dental implantation, which is an essential
function in regenerative dentistry. The potential of GO was demonstrated to induce the
odontoblastic or osteogenic differentiation of dental pulp stem cells (DPSCs) without the
use of any chemical inductors [84]. However, GOBMs are also utilized in the inhibition of
bacterial biofilm formation, membranes, resin, cement, and teeth whitening [85]. Ti, as a
metal-based implant, is the best replacement for teeth due to its excellent biocompatibility,
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high corrosion resistance, and long-term performance; however, Ti has a relatively weak
shear strength. The surface treatment of Ti with GOBMs enhances the mechanical implant
properties and also exhibits a uniform and widely spread roughness, which affects stem
cell [81,85–87] bacterial contamination, causes impaired osteogenesis, and is an essential
challenge after dental implantation [88]. The presence of GO, coated on Ti(GO-Ti), has
shown enhanced antibacterial properties. Immobilized GO on Ti limits the inhibition
growth of bacteria, although the addition of antibiotics (e.g., minocycline hydrochloride) or
silver nanoparticles is recommended [79,86] (Figure 6). Compared with Ti-based implants,
the combination of zirconia (ZrO2) and GO in dental implants resulted in healthier sur-
rounding tissue and fewer bacteria growth, in addition to possessing enhanced mechanical
features (bending strength increased by 200%, toughness increased by 41%) [89]. The
combination of GO with resins, cement, and adhesives inhibits bacterial growth in the oral
cavity [85]. Barrier membranes are used in oral surgical procedures for bone augmentation.
Membranes can be made of different materials, such as collagen. The presence of GO
on the collagen membrane affects the mechanical properties that promote osteoblastic
differentiation and decrease inflammation [87]. The last application of GOBMs in the
dental field is in teeth whitening, which is based on hydrogen peroxide (H2O2) and GOBM
nanocomposites. This combination enhanced the whitening effect of H2O2 and decreased
treatment time [85].
–
Figure 6. The prohibition effect of GO on biofilm formation. Reused with permission from [90].
Copyright © 2021 WILEY-VCH Verlag GmbH and Co. KGaA, Weinheim.
Table 2. The most common stem cells utilized in each tissue [24,26,32,90].
Tissue Stem cells
Bone hMSCs, hADMSCs, MC3T3-E1, DPSCs, PDLSCs
Nerve NSCs, hMSCs, hADMSCs, ESCs, iPSCs, SCAP
Muscle and cardiac C2C12, MSCs, hMSCs, cardiomyocytes, and EC
Cartilage Human mesenchymal stem cell
Skin MSCs, human dermal fibroblasts (HDFs)
Dental DPSCs, PDLSCs, hMSCs, BMSCs
Keys: hADMSCs, human adipose-derived mesenchymal stem cells; DPSCs, dental pulp stem cells; PDLSCs,
periodontal ligament stem cells; NSCs, neural stem cells; ESCs, embryonic stem cells; iPSCs, induced pluripotent
stem cells; SCAP, stem cell from apical papilla; BMSCs, bone-marrow-derived stem cells; C2C12, mouse myoblasts;
EC, endothelial cells.
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5. Conclusions
Graphene oxide has raised considerable interest in tissue engineering and regenerative
medicine due to its specific characteristics, e.g., exceptional mechanical properties and
electrical conductivity, as well as physiochemical, antibacterial, and biological capabilities.
The biological features of GOBMs depend on many parameters, including concentration,
size, shape, and surface chemistry. Within GOBMs, FGO and rGO exhibited the greatest
antibacterial capability. Moreover, GOBMs in various forms of 2D and 3D structures could
stimulate the proliferation and differentiation of cells to a specific lineage, designated
to chemical reactions with biomolecules. Growth factors, small molecules, and ECM
proteins force cell differentiation via GOBMs’ π–π and hydrophobic interactions. The main
challenges associated with utilizing GOBMs are toxicity, the lack of a detailed mechanism
of GOBMs’ biological features, and the explanation of the biological pathway, which has
still not been clarified in depth. Moreover, most research has concentrated on toxicity
at the cellular level instead of at the genetic level. GOBMs can interact with different
biomolecules, especially the DNA; therefore, studies are needed to elucidate the apoptosis
pathway. ROS production, which causes cell death, has been studied more, along with lung,
liver, intestine, and kidney tissues, than other tissues, e.g., nerve, muscle, cardiac, bone,
skin, cartilage, and dental tissue. The application of GOBMs in biomedicine is summarized
in Figure 7.
’ π–π and hydrophobic interactions. 
s’ biological features, and 
Figure 7. Graphical conclusion.
6. Future Direction
The long-term toxicity of GOBMs, known as a primary hurdle, has limited experi-
mental data, and further research investigating their effects is necessary (Figure 8). This
uncertainty has impeded widespread access to clinics; therefore, ensuring human safety
is a priority for these biomaterials. In other words, to achieve the best clinical outcomes,
it is essential to consider solutions to overcome the possible challenges of GOBMs, such
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as their toxicity and biodegradability; for example, by developing standardized parame-
ters for GOBMs utilization, as their toxicity and biological features are intertwined with
physicochemical parameters. Another solution that could minimize these drawbacks is
fabricating biocomposites. It is worth noting that the dose- and time-dependent effects of
GOBMs dictate whether or not ROS scavenging or oxidative stress affects cells detrimen-
tally. The interaction of GOBMs at the genetic level should be considered as well, as they
can interact with DNA and result in alterations of the genetics in the human population.
Although research on GOBMs is still in an early stage, due to its versatile properties, it
will provide extensive applications for biomaterial science and regenerative medicines. We
have been working on the development of functionalized graphene oxide (FGO)-based
nanocomposite materials for biomedical applications [82]. The two families of materials
developed are Hastalex™, a nonbiodegrable nanocomposite for applications such as heart
valves [50], tendons, and breast implants, and a bioabsorbance version (BioHastalex™),
which has been used for nerve regeneration and tissue engineering applications, as well as
for other industries such as the textile industry, with sustainably produced, nontoxic, and
biodegradable materials in the ocean (Nanoloom.co.uk).
loped are Hastalex™
talex™)
Figure 8. Schematic illustration of the cellular toxicity of GOBMs when exposed to the cell. GOBMs enter the cell through
various pathways, which affects their shape, size, and surface chemistry and eventually results in ROS production. An
increased ROS level may cause mitochondrial membrane depolarization and Ca2+ release; lipid, protein, and DNA damage;
and inflammation response by releasing cytokines and chemokines.
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